INMD
InMode·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 2
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
High Cash/net Profit Ratio
Revenue Beats Expectation
Undervalued
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About INMD
Inmode Ltd.
A leading global provider of radio frequency devices that used in minimally & non-invasive cosmetic procedure and women's health
Healthcare Equipment and Supplies
01/02/2008
08/08/2019
NASDAQ Stock Exchange
581
12-31
Common stock
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, 2069206, Israel
--
InMode Ltd., incorporated in the State of Israel as a limited liability company on January 2, 2008, operates under its laws. The company is a leading global provider of innovative, energy-based minimally invasive surgical medical solutions. In the global aesthetics market, their products and solutions are primarily designed to address three energy-based therapeutic categories, including: (i) facial and body contouring; (ii) medical aesthetics; and (iii) women's health.
Earnings Call
Q1/2025
Estimate EPS0.35
Actual EPS0.31
Estimate Revenue77.57M
Actual Revenue77.87M
InMode's Q1 2025: Navigating Contradictions in Revenue Mix, Economic Guidance, and Market Strategies
May 16,2025 03:38
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.41
Actual EPS0.47
Estimate Revenue94.22M
Actual Revenue95.60M
InMode Ltd.'s Q2 2025: Contradictions Unveiled on Economic Outlook, Gross Margins, and Capital Equipment Sales
Jul 30,2025 03:30
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
INMD has released its 2025 Q3 earnings. EPS was reported at 0.38, versus the expected 0.35, beating expectations. The chart below visualizes how INMD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
INMD has released its 2025 Q3 earnings report, with revenue of 93.17M, reflecting a YoY change of -28.46%, and net profit of 21.86M, showing a YoY change of -57.12%. The Sankey diagram below clearly presents INMD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
